PT-141 (bremelanotide, CAS 189691-06-3, molecular formula C50H68N14O10) is a synthetic cyclic heptapeptide and melanocortin receptor agonist studied for its interaction with melanocortin receptor pathways, particularly the MC4R and MC3R receptors. PhaseOne supplies PT-141 to researchers across Australia as a high-purity lyophilised powder, independently HPLC verified at ≥99% purity per batch.
As a melanocortin analogue structurally related to Melanotan II, PT-141 is studied within Australian peptide research for melanocortin receptor signalling, manufactured to research-grade standards and independently third-party tested for identity and consistency, with every order shipped Australia-wide. (!) Full Certificate of Analysis available for every batch view here.
PT-141 — also known as bremelanotide — is a synthetic cyclic heptapeptide and melanocortin receptor agonist, studied within Australian peptide research for its interaction with melanocortin receptors, particularly MC4R and MC3R.
PT-141 is a melanocortin analogue structurally related to Melanotan II; both are studied for melanocortin receptor pathways, but they have distinct structures and research profiles. (!) View our Melanotan II.
Unreconstituted PT-141 should be stored refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research preparation. (!) Read our reconstitution guide.
Each PhaseOne batch is independently verified by third-party HPLC analysis, with a Certificate of Analysis available for every order shipped across Australia.
PT-141 is studied within the melanocortin peptide research category, alongside related melanocortin analogues. (!) Explore more in our peptide guides.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
